ATE281167T1 - Verwendung von makroliden zur behandlung von trockenen augen - Google Patents
Verwendung von makroliden zur behandlung von trockenen augenInfo
- Publication number
- ATE281167T1 ATE281167T1 AT00921047T AT00921047T ATE281167T1 AT E281167 T1 ATE281167 T1 AT E281167T1 AT 00921047 T AT00921047 T AT 00921047T AT 00921047 T AT00921047 T AT 00921047T AT E281167 T1 ATE281167 T1 AT E281167T1
- Authority
- AT
- Austria
- Prior art keywords
- macrolids
- dry eyes
- treat dry
- treat
- eyes
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/04—Artificial tears; Irrigation solutions
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Ophthalmology & Optometry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13200999P | 1999-04-30 | 1999-04-30 | |
PCT/JP2000/002756 WO2000066122A1 (en) | 1999-04-30 | 2000-04-26 | Use of macrolide compounds for the treatment of dry eye |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE281167T1 true ATE281167T1 (de) | 2004-11-15 |
Family
ID=22452015
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT00921047T ATE281167T1 (de) | 1999-04-30 | 2000-04-26 | Verwendung von makroliden zur behandlung von trockenen augen |
Country Status (23)
Country | Link |
---|---|
EP (1) | EP1173177B2 (de) |
JP (2) | JP5036934B2 (de) |
KR (1) | KR20020015316A (de) |
CN (1) | CN1190194C (de) |
AR (1) | AR023807A1 (de) |
AT (1) | ATE281167T1 (de) |
AU (1) | AU777915B2 (de) |
BR (1) | BR0011225A (de) |
CA (1) | CA2372448A1 (de) |
CZ (1) | CZ20013769A3 (de) |
DE (1) | DE60015516T2 (de) |
ES (1) | ES2232439T3 (de) |
HK (2) | HK1043321B (de) |
HU (1) | HUP0200864A3 (de) |
IL (1) | IL146162A0 (de) |
MX (1) | MXPA01010988A (de) |
NO (1) | NO20015288L (de) |
NZ (1) | NZ515339A (de) |
PT (1) | PT1173177E (de) |
TR (1) | TR200103119T2 (de) |
TW (1) | TWI230066B (de) |
WO (1) | WO2000066122A1 (de) |
ZA (1) | ZA200108905B (de) |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CZ20013769A3 (cs) * | 1999-04-30 | 2002-03-13 | Sucampo Ag | Činidlo pro léčbu suchého oka |
US20070032853A1 (en) | 2002-03-27 | 2007-02-08 | Hossainy Syed F | 40-O-(2-hydroxy)ethyl-rapamycin coated stent |
NZ530845A (en) | 2001-07-06 | 2006-03-31 | Sucampo Ag | Composition for topical administration |
PE20030828A1 (es) * | 2002-03-04 | 2003-11-04 | Novartis Ag | Composicion oftalmica que comprende ascomicina |
WO2004014373A1 (en) * | 2002-08-09 | 2004-02-19 | Sucampo Pharmaceuticals, Inc. | Pharmaceutical compositions comprising fk506 derivatives and the ir use for the treatment of allergic diseases |
US7354574B2 (en) | 2002-11-07 | 2008-04-08 | Advanced Ocular Systems Limited | Treatment of ocular disease |
AR042890A1 (es) * | 2003-01-16 | 2005-07-06 | Sucampo Pharmaceuticals Inc | Metodo de tratamiento del ojo seco con una composicion oftalmica que contiene un compuesto macrolido |
US20050118344A1 (en) | 2003-12-01 | 2005-06-02 | Pacetti Stephen D. | Temperature controlled crimping |
US7083802B2 (en) * | 2003-07-31 | 2006-08-01 | Advanced Ocular Systems Limited | Treatment of ocular disease |
US7087237B2 (en) | 2003-09-19 | 2006-08-08 | Advanced Ocular Systems Limited | Ocular solutions |
US7083803B2 (en) | 2003-09-19 | 2006-08-01 | Advanced Ocular Systems Limited | Ocular solutions |
CN1863522A (zh) | 2003-10-06 | 2006-11-15 | 欧得士株式会社 | 治疗泪液异常用的眼科用组合物 |
PL1848431T3 (pl) | 2005-02-09 | 2016-08-31 | Santen Pharmaceutical Co Ltd | Ciekłe formulacje do leczenia chorób lub stanów |
PL1904056T3 (pl) | 2005-07-18 | 2009-09-30 | Minu Llc | Zastosowanie makrolidu do przywracania czucia rogówkowego |
CN101605529B (zh) | 2006-02-09 | 2013-03-13 | 参天制药株式会社 | 稳定制剂及它们的制备和使用方法 |
BRPI0709016A2 (pt) | 2006-03-23 | 2011-06-21 | Macusight Inc | formulações e métodos para doenças ou condições relacionadas com a permeabilidade vascular |
EP2335735A1 (de) * | 2009-12-14 | 2011-06-22 | Novaliq GmbH | Pharmazeutische Zusammensetzung zur Behandlung von trockenem Auge |
JP7278969B2 (ja) * | 2017-05-30 | 2023-05-22 | エキシモア・リミテッド | ドライアイ症候群を治療するための抗生物質マクロライドを送達する組成物および方法 |
WO2019060696A1 (en) | 2017-09-25 | 2019-03-28 | Surface Pharmaceuticals, Inc. | OPTHALMIC PHARMACEUTICAL COMPOSITIONS AND METHODS FOR THE TREATMENT OF OCULAR SURFACE DISEASE |
MX2021007709A (es) | 2018-12-27 | 2021-12-15 | Surface Ophthalmics Inc | Composiciones farmacéuticas oftálmicas y procedimientos para el tratamiento de las enfermedades de la superficie ocular. |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69016515T2 (de) * | 1989-07-05 | 1995-06-08 | Fujisawa Pharmaceutical Co | Wässriges flüssiges Mittel zur äusserlichen Anwendung. |
KR100237715B1 (ko) * | 1991-04-26 | 2000-02-01 | 후지야마 아키라 | 안과질환에 대한 마크로라이드 화합물의 용도 |
ZA924953B (en) * | 1991-07-25 | 1993-04-28 | Univ Louisville Res Found | Method of treating ocular inflammation |
AR004480A1 (es) * | 1995-04-06 | 1998-12-16 | Amico Derin C D | Compuestos de ascomicina que poseen actividad antiinflamatoria, pro cedimiento para prepararlos, uso de dichos compuestos para preparar agentesfarmaceuticos y composiciones farmaceuticas que los incluyen |
GB9601120D0 (en) * | 1996-01-19 | 1996-03-20 | Sandoz Ltd | Organic compounds |
US6673807B1 (en) * | 1998-04-06 | 2004-01-06 | Fujisawa Pharmaceutical Co., Ltd. | Immunosuppressive imidazole derivatives and their combination preparations with tacrolimus or cyclosporins |
PL343627A1 (en) * | 1998-04-27 | 2001-08-27 | Fujisawa Pharmaceutical Co | Medicinal compositions |
US6376517B1 (en) * | 1998-08-14 | 2002-04-23 | Gpi Nil Holdings, Inc. | Pipecolic acid derivatives for vision and memory disorders |
CZ20013769A3 (cs) * | 1999-04-30 | 2002-03-13 | Sucampo Ag | Činidlo pro léčbu suchého oka |
-
2000
- 2000-04-26 CZ CZ20013769A patent/CZ20013769A3/cs unknown
- 2000-04-26 ES ES00921047T patent/ES2232439T3/es not_active Expired - Lifetime
- 2000-04-26 CN CNB008067686A patent/CN1190194C/zh not_active Expired - Fee Related
- 2000-04-26 EP EP00921047.7A patent/EP1173177B2/de not_active Expired - Lifetime
- 2000-04-26 MX MXPA01010988A patent/MXPA01010988A/es active IP Right Grant
- 2000-04-26 AU AU41429/00A patent/AU777915B2/en not_active Ceased
- 2000-04-26 JP JP2000615007A patent/JP5036934B2/ja not_active Expired - Fee Related
- 2000-04-26 PT PT00921047T patent/PT1173177E/pt unknown
- 2000-04-26 BR BR0011225-9A patent/BR0011225A/pt not_active IP Right Cessation
- 2000-04-26 KR KR1020017013768A patent/KR20020015316A/ko not_active Application Discontinuation
- 2000-04-26 TR TR2001/03119T patent/TR200103119T2/xx unknown
- 2000-04-26 NZ NZ515339A patent/NZ515339A/xx unknown
- 2000-04-26 AT AT00921047T patent/ATE281167T1/de active
- 2000-04-26 CA CA002372448A patent/CA2372448A1/en not_active Abandoned
- 2000-04-26 WO PCT/JP2000/002756 patent/WO2000066122A1/en not_active Application Discontinuation
- 2000-04-26 TW TW089107899A patent/TWI230066B/zh not_active IP Right Cessation
- 2000-04-26 DE DE60015516T patent/DE60015516T2/de not_active Expired - Lifetime
- 2000-04-26 HU HU0200864A patent/HUP0200864A3/hu unknown
- 2000-04-26 IL IL14616200A patent/IL146162A0/xx unknown
- 2000-04-28 AR ARP000102060A patent/AR023807A1/es not_active Application Discontinuation
-
2001
- 2001-10-29 NO NO20015288A patent/NO20015288L/no not_active Application Discontinuation
- 2001-10-29 ZA ZA200108905A patent/ZA200108905B/xx unknown
-
2002
- 2002-07-12 HK HK02105192.3A patent/HK1043321B/zh not_active IP Right Cessation
- 2002-10-24 HK HK02107726.4A patent/HK1046099A1/zh unknown
-
2012
- 2012-02-03 JP JP2012022420A patent/JP2012116857A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
DE60015516D1 (de) | 2004-12-09 |
NO20015288D0 (no) | 2001-10-29 |
HK1046099A1 (zh) | 2002-12-27 |
CA2372448A1 (en) | 2000-11-09 |
WO2000066122A1 (en) | 2000-11-09 |
NZ515339A (en) | 2004-02-27 |
AU4142900A (en) | 2000-11-17 |
KR20020015316A (ko) | 2002-02-27 |
DE60015516T2 (de) | 2005-12-01 |
TR200103119T2 (tr) | 2002-04-22 |
ZA200108905B (en) | 2002-12-24 |
EP1173177B1 (de) | 2004-11-03 |
JP2002543132A (ja) | 2002-12-17 |
AR023807A1 (es) | 2002-09-04 |
NO20015288L (no) | 2001-10-29 |
AU777915B2 (en) | 2004-11-04 |
TWI230066B (en) | 2005-04-01 |
HK1043321B (zh) | 2005-07-15 |
JP5036934B2 (ja) | 2012-09-26 |
PT1173177E (pt) | 2005-03-31 |
MXPA01010988A (es) | 2004-04-21 |
CN1353608A (zh) | 2002-06-12 |
IL146162A0 (en) | 2002-07-25 |
BR0011225A (pt) | 2002-03-19 |
JP2012116857A (ja) | 2012-06-21 |
HUP0200864A2 (hu) | 2002-07-29 |
CZ20013769A3 (cs) | 2002-03-13 |
EP1173177A1 (de) | 2002-01-23 |
HK1043321A1 (en) | 2002-09-13 |
CN1190194C (zh) | 2005-02-23 |
EP1173177B2 (de) | 2014-03-05 |
HUP0200864A3 (en) | 2004-07-28 |
ES2232439T3 (es) | 2005-06-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60015516D1 (de) | Verwendung von makroliden zur behandlung von trockenen augen | |
ATE419856T1 (de) | Verwendung von rimexolon zur behandlung von augentrockenheit | |
ATE288748T1 (de) | Verwendung von retigabin zur behandlung von neuropathischen schmerzen | |
ATE365042T1 (de) | Verwendung von morpholinol zur behandlung von sexuellen funktionsstörungen | |
DE69903543D1 (de) | Formulierungen zur behandlung von magen-speiseröhren reflux | |
DE69838338D1 (de) | Verwendung von antimykotica zur topischen behandlung von pilz-induzierten schleimhautentzündungen | |
ATE475427T1 (de) | Verwendung von botulinum toxin zur behandlung von eingweideschmerzen | |
DE69926385D1 (de) | Behandlung von geweben | |
DE69918687D1 (de) | 4-phenylpiperidine zur behandlung von prutitischen hauterkrankungen | |
DE69925306D1 (de) | Behandlung von kohlenwasserstoffgas | |
DE69813935D1 (de) | Verwendung von Retinoiden zur Induzierung von Hautpigmentierung | |
DE60023816D1 (de) | Verwendung von Lycopin in Zusammensetzungen zur Behandlung von Hautalterungs-Erscheinungen | |
ATE353218T1 (de) | Verwendung von epinastin zur behandlung von allergischer rhinitis/konjunktivitis | |
DE60137929D1 (de) | Verwendung von lanthan bei der behandlung von knochenerkrankungen | |
DE69729817D1 (de) | Behandlung von Aldehyd-fixierten Geweben | |
ATE338552T1 (de) | Verwendungen von et743 zur behandlung von krebs | |
ATE218862T1 (de) | Verwendung von 1-hydroxy-2-pyridonen zur behandlung von hautinfektionen | |
DE69702862D1 (de) | Verwendung von sulfatierten polysacchariden zur behandlung einer chronischer verletzung | |
ATE390474T1 (de) | Verwendung von polymerem material zur behandlung harter oberflächen | |
ATE410181T1 (de) | Verwendung von intereferon gamma zur behandlung von herzhypertrophie | |
ATE270102T1 (de) | Verwendung von benzopyranolen zur behandlung von neurologischen erkrankungen | |
ATE317261T1 (de) | Verwendung von mirtazapin zur behandlung von schlafstörungen | |
ATE330596T1 (de) | Verwendung von 3-bezoylphenylessigsäure-derivaten zur behandlung von netzhauterkrankungen | |
ATE190486T1 (de) | Verwendung von buckminsterfulleren zur behandlung neurotoxischer verletzungen | |
ATE267608T1 (de) | Verwendung von fsh zur behandlung von infertilität |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1173177 Country of ref document: EP |